Not available.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3324/haematol.2024.287052 | DOI Listing |
Haematologica
January 2025
Clinical Hematology, Nantes University Hospital, Nantes.
Not available.
View Article and Find Full Text PDFHaematologica
January 2025
Department of Clinical Laboratory, South China Hospital, Medical School, Shenzhen University, Shenzhen, 518111.
Not available.
View Article and Find Full Text PDFPharmacoeconomics
December 2024
Centre for Reviews and Dissemination (CRD), University of York, York, YO10 5DD, UK.
Cell Rep Med
January 2024
Division of Hematology-Oncology, Boston, MA 02115, USA; Department of Medicine, Boston, MA 02115, USA; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA. Electronic address:
A study by Régnier et al. shows that Flt3-ligand (FL) levels program two distinct mechanisms of anti-tumor immunity. Low FL levels allow recruitment of T effectors and T cell-mediated responses whereas high FL levels support recruitment of classical dendritic cells (cDC) and natural killer (NK) cells and NK-mediated anti-tumor responses.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!